Sign In

Samuele Butera

President, US Pulmonary Hypertension and Retina

Samuele Butera is the President of US Pulmonary Hypertension and Retina at Johnson & Johnson Innovative Medicine. He holds a significant leadership role within the company, focusing on advancing treatments and innovations in these specialized medical areas. His professional insights and activities can be found on his LinkedIn profile, where he shares updates related to his work and initiatives in healthcare.12

Highlights

Aug 22 · linkedin

It was invigorating to speak with so many members of the #PulmonaryArterialHypertension (#PAH) community at the Pulmonary Hypertension Association 2024 conference. In one such conversation, Gerry Langan clearly articulated the value of connecting with the community: “The PAH conference brings so much hope to this community because we get to see people that are farther along on their journeys than we are, and it gives us hope.”

Like Gerry, many patients took part in the immersive experience we created on the foundational #PAH treatment pathways. This exhibit was based on years of research and conversations with people like them who found the courage to share their experiences.

As we continue to work to transform lives in this area, we’ll ground our efforts in creating and learning from conversations like the ones we had at #PHA2024. The PAH community can rest assured we’re championing their perspectives at each step of the treatment journey.

#MyCompany

Aug 15 · linkedin

For over 20 years, Johnson & Johnson Innovative Medicine has partnered with patients, physicians, and care teams to understand their experiences and help bring them to life so we can expand education and awareness in this space. I can’t think of a better reflection of this effort than how our team is showing up at the Pulmonary Hypertension Association this year.    Navigating a rare disease like pulmonary arterial hypertension (PAH) often isn’t a clear path. The insights we’ve gained from our ongoing conversations with people living with this condition have inspired us to create an immersive experience at the PHA 2024 International PH Conference and Scientific Sessions to help people explore the pathways they might take to manage living with PAH. The creation of this immersive experience could not have been done without the years of extensive research into the pathways of PAH, and commitment to scientific excellence.   If you’re attending PHA 2024 in Indianapolis, stop by our booth to learn more about the foundational pathways of PAH.     #PHA2024 #PassionAdvancementHope #MyCompany

Related Questions

What are Samuele Butera's main responsibilities at Johnson & Johnson Innovative Medicine?
How long has Samuele Butera been in his current role?
What are some notable achievements of Samuele Butera in his career?
What is Samuele Butera's educational background?
How has Samuele Butera contributed to the field of pulmonary hypertension?
Samuele Butera
Samuele Butera, photo 1
Samuele Butera, photo 2
Add to my network

Location

New York City Metropolitan Area